Related Experiment Video

Updated: Aug 3, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities

Gerald F Watts1

  • 1Department of Medicine, Royal Perth Hospital, University of Western Australia, Perth, Australia. gfwatts@cyllene.uwa.edu.au

Current Controlled Trials in Cardiovascular Medicine
|January 25, 2002
PubMed

Insights

Lipid-regulating therapies, including fibrates and statins, effectively reduce cardiovascular events in individuals with low high-density lipoprotein (HDL)-cholesterol. Optimal management necessitates lifestyle changes and potentially revised HDL-cholesterol and triglyceride targets.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • Low high-density lipoprotein (HDL)-cholesterol is a significant cardiovascular risk factor.
  • Normocholesterolaemic individuals with low HDL-cholesterol represent a target population for lipid-modulating therapies.
  • Existing research highlights the need for effective interventions in this demographic.

Purpose of the Study:

  • To evaluate the efficacy of lipid-regulating therapies in patients with normocholesterolaemia and low HDL-cholesterol.
  • To compare the cardiovascular risk reduction achieved by fibrates and statins in specific clinical trial settings.
  • To provide recommendations for lifestyle and pharmacological management of low HDL-cholesterol.

Main Methods:

  • Analysis of data from three key clinical trials: VA-HIT, BIP, and AFCAPS/TexCAPS.
  • Comparison of absolute risk reduction in coronary events across different therapeutic interventions.
  • Review of secondary and primary prevention study outcomes.

Main Results:

  • Fibrates demonstrated efficacy in reducing cardiovascular events, particularly in patients with hypertriglyceridaemia (VA-HIT, BIP).
  • Statins proved effective in decreasing acute coronary events in primary prevention for isolated low HDL-cholesterol (AFCAPS/TexCAPS).
  • Absolute risk reductions in trials like VA-HIT and AFCAPS/TexCAPS were comparable to other major cardiovascular studies.

Conclusions:

  • Lipid-regulating therapies offer significant cardiovascular benefits for individuals with low HDL-cholesterol.
  • Current management strategies should include lifestyle modifications and consideration of updated treatment targets for HDL-cholesterol and triglycerides.
  • Further review of therapeutic targets is essential for optimal patient outcomes.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...